BeOne Medicines AG - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US07725L1026

SecurityONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionAsset Management One Co., Ltd.
Latest Disclosed Ownership21,346 shares
Latest Disclosed Value $ 6,339,122
Asset Management One Co., Ltd. reports 6.74% increase in ownership of ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 8, 2026 - Asset Management One Co., Ltd. filed a 13F-HR form disclosing ownership of 21,346 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (US:ONC) valued at $6,339,122 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 19,998 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 6.74% during the quarter. The current value of the position is $5,975,386 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 21,346 1,348 6.74 6,339 2.16 0.0187
2026-01-27 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 19,998 88 0.44 6,205 -8.52 0.0173
2025-10-22 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 19,910 -543 -2.65 6,783 37.00 0.0197
2025-07-31 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 20,453 0 0.00 4,951 -11.05 0.0155
2025-04-23 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 20,453 0 0.00 5,567 49.62 0.0193
2025-01-30 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 20,453 0 0.00 3,720 -18.97 0.0128
2024-10-30 2024-09-30 13F BEIGENE SPONSORED ADR 07725L102 20,453 2,593 14.52 4,592 80.18 0.0163
2024-07-18 2024-06-30 13F BEIGENE SPONSORED ADR 07725L102 17,860 0 0.00 2,548 -8.77 0.0097
2024-05-02 2024-03-31 13F BEIGENE SPONSORED ADR 07725L102 17,860 0 0.00 2,793 -12.85 0.0108
2024-01-24 2023-12-31 13F BEIGENE SPONSORED ADR 07725L102 17,860 0 0.00 3,206 -0.22 0.0129
2023-10-19 2023-09-30 13F BEIGENE SPONSORED ADR 07725L102 17,860 0 0.00 3,212 0.88 0.0143
2023-07-31 2023-06-30 13F BEIGENE SPONSORED ADR 07725L102 17,860 1,377 8.35 3,184 -10.36 0.0135
2023-04-25 2023-03-31 13F BEIGENE SPONSORED ADR 07725L102 16,483 0 0.00 3,553 -3.71 0.0161
2023-02-06 2022-12-31 13F BEIGENE SPONSORED ADR 07725L102 16,483 -10,972 -39.96 3,689 -0.32 0.0180
2022-11-04 2022-09-30 13F BEIGENE SPONSORED ADR 07725L102 27,455 1,635 6.33 3,701 -11.42 0.0188
2022-07-29 2022-06-30 13F BEIGENE SPONSORED ADR 07725L102 25,820 -130 -0.50 4,178 -14.63 0.0196
2022-05-13 2022-03-31 13F BEIGENE SPONSORED ADR 07725L102 25,950 995 3.99 4,894 -24.81 0.0191
2022-02-09 2021-12-31 13F BEIGENE SPONSORED ADR 07725L102 24,955 -2,414 -8.82 6,509 -34.48 0.0227
2021-11-02 2021-09-30 13F BEIGENE SPONSORED ADR 07725L102 27,369 386 1.43 9,934 7.28 0.0381
2021-08-03 2021-06-30 13F BEIGENE SPONSORED ADR 07725L102 26,983 -1,248 -4.42 9,260 -5.76 0.0345
2021-05-14 2021-03-31 13F BEIGENE SPONSORED ADR 07725L102 28,231 -717 -2.48 9,826 38.55 0.0390
2021-02-12 2020-12-31 13F BEIGENE SPONSORED ADR 07725L102 28,948 -243 -0.83 7,092 -15.16 0.0292
2020-11-13 2020-09-30 13F BEIGENE SPONSORED ADR 07725L102 29,191 78 0.27 8,359 52.40 0.0384
2020-08-14 2020-06-30 13F BEIGENE SPONSORED ADR 07725L102 29,113 2,271 8.46 5,485 66.06 0.0270
2020-05-14 2020-03-31 13F BEIGENE SPONSORED ADR 07725L102 26,842 340 1.28 3,303 -24.81 0.0193
2020-02-14 2019-12-31 13F BEIGENE SPONSORED ADR 07725L102 26,502 821 3.20 4,393 39.68 0.0198
2019-11-14 2019-09-30 13F BEIGENE SPONSORED ADR 07725L102 25,681 277 1.09 3,145 -0.16 0.0152
2019-08-14 2019-06-30 13F BEIGENE SPONSORED ADR 07725L102 25,404 2,070 8.87 3,150 2.31 0.0155
2019-05-15 2019-03-31 13F BEIGENE SPONSORED ADR 07725L102 23,334 -29,432 -55.78 3,079 -58.37 0.0167
2019-02-13 2018-12-31 13F BEIGENE SPONSORED ADR 07725L102 52,766 52,766 7,396 0.0176
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.